DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma.

Yuan, Mengping; Xu, Jinyong; Cao, Shuguang; Sun, Shuangshuang

Yuan, Mengping; Xu, Jinyong; Cao, Shuguang; Sun, Shuangshuang.

Afiliação

Yuan M; Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China.
Xu J; Department of Pathology, Shenzhen Hyzen Hospital, Shenzhen, 518038, People's Republic of China.
Cao S; Department of Gastroenterology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China. letous202@163.com.
Sun S; Department of Oncology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325000, People's Republic of China. 459200804@qq.com.

BMC Immunol ; 23(1): 59, 2022 11 30.

Article em En | MEDLINE | ID: mdl-36451087

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Carcinoma Hepatocelular/genética; Prognóstico; Neoplasias Hepáticas/genética; Bases de Dados Factuais; Biomarcadores; RNA Helicases DEAD-box/genética

Palavras-chave

DDX1; Hepatocellular carcinoma; Infiltration immune cells; Methylation; Prognostic biomarker; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: BMC Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google